CROíVALVE
CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
CROíVALVE
Industry:
Medical Device
Founded:
2016-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.croivalve.com
Total Employee:
1+
Status:
Active
Total Funding:
17.18 M USD
Technology used in webpage:
Microsoft Exchange Online Organization Schema Facebook Sharer Pinterest
Similar Organizations
GuRu
Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Ava
Ava is a patented multi-sensor bracelet, which allows women to precisely and conveniently predict fertile days.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
OxSonics Therapeutics
OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Unchained Labs
Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it.
Current Employees Featured
Founder
Investors List
Broadview Ventures
Broadview Ventures investment in Series A - CroíValve
Elkstone Capital Partners
Elkstone Capital Partners investment in Series A - CroíValve
Halo Business Angel Network
Halo Business Angel Network investment in Series A - CroíValve
Dublin Business Innovation Centre
Dublin Business Innovation Centre investment in Series A - CroíValve
Atlantic Bridge University Fund
Atlantic Bridge University Fund investment in Series A - CroíValve
Enterprise Ireland
Enterprise Ireland investment in Series A - CroíValve
Irrus Investments
Irrus Investments investment in Series A - CroíValve
SOSV
SOSV investment in Series A - CroíValve
Ascentifi
Ascentifi investment in Series A - CroíValve
HBAN Medtech Syndicate
HBAN Medtech Syndicate investment in Seed Round - CroíValve
Official Site Inspections
http://www.croivalve.com Semrush global rank: 9.55 M Semrush visits lastest month: 141
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CroíValve"
Team - CroiValve
CroíValve is an early stage medical device company focused on developing a minimally invasive device for the treatment of tricuspid regurgitation.See details»
Home - CroiValve
Introduction . CroíValve is developing a Best-In-Class minimally invasive solution for severe Tricuspid Regurgitation (TR). It is a clear unmet clinical need, with a significant impact on mortality, cardiovascular events and quality of life.See details»
CroíValve - Crunchbase Company Profile & Funding
Medical Product Outsourcing — MedTech & Irrus Syndicates Lead Study Funding for CroiValve's Transcatheter Tricuspid Device News • Aug 8, 2024 Silicon …See details»
CroiValve - LinkedIn
CroiValve | 7,645 followers on LinkedIn. Treating Heart Valve Disease | CroíValve is an early-stage medical device company developing a unique transcatheter device to repair the tricuspid valve.See details»
CroiValve 2025 Company Profile: Valuation, Funding & Investors
CroiValve General Information Description. Developer of a minimally invasive surgical device designed to treat severe tricuspid regurgitation. The company's device can be delivered …See details»
Contact - CroiValve - CroíValve
Unit A Liffey Trust Enterprise Centre, 117-125 Sheriff Street Upper, Dublin 1, Ireland D01 F6P0See details»
CroíValve - Contacts, Employees, Board Members, Advisors
CroíValve is a developed safe, effective, easy to use, percutaneous solution company.See details»
CroíValve - Funding, Financials, Valuation & Investors - Crunchbase
CroíValve is a developed safe, effective, easy to use, percutaneous solution company.See details»
Croivalve - SOSV
Jan 26, 2024 CroíValve is developing a transcatheter device to treat Tricuspid Regurgitation, a common heart valve disorder for which there are no commercially-available, minimally-invasive solutions. CroíValve’s solution, …See details»
CroiValve Ltd - VentureRadar
"CroíValve is a clinical stage medical device company focused on the development of the DUO™ System, a novel transcatheter heart valve. This device works in tandem with the native …See details»
croivalve.com Reviews: Is this site a scam or legit?
After you read why we deemed croivalve.com a low-risk site, please tell us how you came across this platform in the comments.. Scam Detectors Most Trusted Websites in Online Security. …See details»
CroiValve Company Profile - MedTech Innovator
This means there is no suitable treatment option for these sick patients. CroiValve intends to provide them with one, resulting in benefits to patients, physicians, and our healthcare …See details»
CroiValve Company Profile - Office Locations, Competitors ... - Craft
CroiValve is a medical device company developing a transcatheter device to treat defective heart valves. The Company's device is delivered through the heart’s blood vessels and seals the …See details»
CroíValve - Overview, News & Similar companies | ZoomInfo.com
CroíValve contact info: Phone number: +353 12552139 Website: www.croivalve.com What does CroíValve do? CroíValve was founded in 2016 and is a spin-out from EIT Health partner Trinity …See details»
CroiValve Company Overview, Contact Details & Competitors
Croivalve launched First in Human implants of DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation on Mar 1st '20. CroíValve has announced the successful …See details»
CroíValve secures USD 16 million to advance heart valve treatment
Aug 20, 2024 EIT Health-supported start-up, CroíValve, has successfully closed a USD16 million Series B funding round to further develop its innovative heart valve treatment …See details»
CroíValve Raises an €8M Series A Round to Support a Feasibility ...
Croivalve • February 4, 2022. LINDA MACKEN – FEBRUARY 4, 2022. CroíValve, a Dublin based medical device company developing a novel treatment for tricuspid regurgitation, has raised a …See details»
CroiValve Company Information - Funding, Investors, and More
The company CroiValve has raised a total of $16m in funding over 1 rounds. Key Insights: Series B: $16m; 2024. CroiValve Series B (2024, $16M) $16m. Similar startup. GridBeyond …See details»
CroíValve Announces $16 Million Equity Financing to Fund US …
Croivalve • August 7, 2024. CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, …See details»
News - CroiValve - CroíValve
Jul 22, 2022 Transcatheter tricuspid valve implantation in Medical University of Warsaw – TANDEM I study. Many thanks to Dr Martin Quinn and the entire CroiValve team for excellent …See details»